Voltage-gated Na+ channel blockers reduce functional bladder capacity in the conscious spontaneously hypertensive rat

Urology

Volumn 79, Issue 6, 2012, Pages 1410.e1-1410.e6

  Clouse, Angela K ^a   Jugus, Malcolm J ^a   Eisennagel, Stephen H ^a   Laping, Nicholas J ^a   Westfall, Timothy D ^a   Thorneloe, Kevin S ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CARBACHOL; CARBAMAZEPINE; DARIFENACIN; LAMOTRIGINE; MEXILETINE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OLIGODEOXYNUCLEOTIDE; OXYBUTYNIN; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CAPACITY; BLADDER CONTRACTION; BLADDER PRESSURE; CONTROLLED STUDY; CYSTOMETRY; DRUG ACTIVITY; DRUG RESPONSE; FEMALE; MICTURITION; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; URINE VOLUME; URODYNAMICS;

EID: 84861721303     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2012.02.016     Document Type: Article

References (16)

1. M.J. Drake Emerging drugs for treatment of overactive bladder and detrusor overactivity Expert Opin Emerg Drugs 13 2008 431 446
2. B.T. Priest Future potential and status of selective sodium channel blockers for the treatment of pain Curr Opin Drug Discov Dev 12 2009 682 692
3. N. Yoshimura, S. Seki, S.D. Novakovic The involvement of the tetrodotoxin-resistant sodium channel Na(v)1.8 (PN3/SNS) in a rat model of visceral pain J Neurosci 21 2001 8690 8696 (Pubitemid 33051467)
4. J.A. Black, T.R. Cummins, N. Yoshimura Tetrodotoxin-resistant sodium channels Na(v)1.8/SNS and Na(v)1.9/NaN in afferent neurons innervating urinary bladder in control and spinal cord injured rats Brain Res 963 2003 132 138 (Pubitemid 36126293)
5. A.M. Ritter, W.J. Martin, K.S. Thorneloe The voltage-gated sodium channel Nav1.9 is required for inflammation-based urinary bladder dysfunction Neurosci Lett 452 2009 28 32
6. L. Djouhri, X. Fang, K. Okuse The TTX-resistant sodium channel Nav1.8 (SNS/PN3): expression and correlation with membrane properties in rat nociceptive primary afferent neurons J Physiol 550 2003 739 752 (Pubitemid 37010060)
7. W.A. Catterall, A.L. Goldin, S.G. Waxman International Union of Pharmacology. XLVII Nomenclature and structure-function relationships of voltage-gated sodium channels Pharmacol Rev 57 2005 397 409
8. X. Fang, L. Djouhri, S. McMullan Intense isolectin-B4 binding in rat dorsal root ganglion neurons distinguishes C-fiber nociceptors with broad action potentials and high Nav1.9 expression J Neurosci 26 2006 7281 7292
9. J.M. Spitsbergen, D.B. Clemow, R. McCarty Neurally mediated hyperactive voiding in spontaneously hypertensive rats Brain Res 790 1998 151 159 (Pubitemid 28234498)
10. P.B. Patra, K.S. Thorneloe Enhanced sensitivity to afferent stimulation and impact of overactive bladder therapies in the conscious, spontaneously hypertensive rat J Pharmacol Exp Ther 338 2011 392 399
11. M.J. Jugus, J.P. Jaworski, P.B. Patra Dual modulation of urinary bladder activity and urine flow by prostanoid EP3 receptors in the conscious rat Br J Pharmacol 158 2009 372 381
12. Y. Igawa, A. Mattiasson, K.E. Andersson Functional importance of cholinergic and purinergic neurotransmission for micturition contraction in the normal, unanaesthetized rat Br J Pharmacol 109 1993 473 479 (Pubitemid 23161133)
13. P. Ney, R.K. Pandita, D.T. Newgreen Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo BJU Int 101 2008 1036 1042 (Pubitemid 351422555)
14. M.L. Chew, B.H. Mulsant, B.G. Pollock Anticholinergic activity of 107 medications commonly used by older adults J Am Geriatr Soc 56 2008 1333 1341
15. A. van Ophoven, L. Hertle Long-term results of amitriptyline treatment for interstitial cystitis J Urol 174 2005 1837 1840 (Pubitemid 41546956)
16. W.D. Steers, J.B. Tuttle Mechanisms of disease: the role of nerve growth factor in the pathophysiology of bladder disorders Nat Clin Pract Urol 3 2006 101 110 (Pubitemid 43239267)